Ginkgo Bioworks (DNA:ASX) Investor Relations Material

Overview

Boston-based Ginkgo Bioworks Holdings, Inc. and its subsidiaries specialize in developing a powerful platform that can program cells to generate various products such as novel therapeutics, food ingredients and petroleum-based chemicals. The innovative platform is particularly useful across numerous sectors including agriculture, specialty chemicals, pharmaceuticals, consumer products and food. Ginkgo Bioworks Holdings, Inc. was established in 2008 and is committed to transforming the world through the biological engineering of organisms.

Frequently Asked Questions

What is Ginkgo Bioworks's ticker?

Ginkgo Bioworks's ticker is DNA

What exchange is Ginkgo Bioworks traded on?

The company's shares trade on the ASX stock exchange

Where are Ginkgo Bioworks's headquarters?

They are based in Pyrmont, NSW

How many employees does Ginkgo Bioworks have?

There are 1001-5000 employees working at Ginkgo Bioworks

What is Ginkgo Bioworks's website?

It is ginkgobioworks.com

What type of sector is Ginkgo Bioworks?

Ginkgo Bioworks is in the Services sector

What type of industry is Ginkgo Bioworks?

Ginkgo Bioworks is in the Lodging industry

Who are Ginkgo Bioworks's peers and competitors?

The following five companies are Ginkgo Bioworks's industry peers:

- Delta Air Lines

- Wyndham Destinations, Inc.

- Extended Stay America

- InterContinental Hotels Group

- Hilton Worldwide